Freeman Kevin Lee (CIK 1945797) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-03). Recent activity: Sell HCAT (16,401 shares), Sell HCAT (4,578 shares), Sell HCAT (4,747 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-03 | Health Catalyst, Inc. (HCAT) | Chief Commercial Officer | Sell | 16,401 | $47,563 |
| 2025-09-04 | Health Catalyst, Inc. (HCAT) | Chief Commercial Officer | Sell | 4,578 | $15,382 |
| 2025-06-03 | Health Catalyst, Inc. (HCAT) | Chief Commercial Officer | Sell | 4,747 | $17,232 |
来源：SEC Form 4 申报文件 · 截至 2025-12-03